Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Skin neoplasms malignant and unspecified (excl melanoma)
ADR ID BADD_A04054
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.08      Skin neoplasms malignant and unspecified
23.08.02      Skin neoplasms malignant and unspecified (excl melanoma)
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.03      Skin neoplasms malignant and unspecified
16.03.02      Skin neoplasms malignant and unspecified (excl melanoma)
Description Not Available
MedDRA Code 10040901
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02031Sitaxentan--
BADD_D02047Sodium oxybate0.000590%
BADD_D02058Sorafenib0.000907%
BADD_D02066Spironolactone0.000073%
BADD_D02093Sulfasalazine0.000303%
BADD_D02104Tacrine hydrochloride--
BADD_D02105Tacrolimus0.013961%
BADD_D02106Tadalafil0.000195%
BADD_D02107Tafamidis0.000538%
BADD_D02150Temozolomide0.000112%
BADD_D02154Tenofovir0.004265%
BADD_D02165Teriflunomide0.000964%
BADD_D02192Thalidomide0.001929%
BADD_D02210Tiagabine--
BADD_D02211Tiagabine hydrochloride--
BADD_D02230Tizanidine--
BADD_D02231Tizanidine hydrochloride--
BADD_D02236Tofacitinib0.022906%
BADD_D02237Tofacitinib citrate--
BADD_D02241Tolcapone--
BADD_D02252Tositumomab--
BADD_D02257Trametinib0.000168%
BADD_D02322Ustekinumab--
BADD_D02325Valdecoxib--
BADD_D02331Valsartan0.000423%
BADD_D02344Vemurafenib0.007421%
BADD_D02345Venetoclax0.000336%
BADD_D02365Vismodegib0.007331%
BADD_D02367Voltaren--
BADD_D02369Voriconazole0.212011%
The 5th Page    First    Pre   5 6    Next   Last    Total 6 Pages